List of bibliographic references indexed by Drug Tolerance
Number of relevant bibliographic references: 28.
[0-20] [
0 - 20][
0 - 28][
20-27][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000345 (2015) |
Adriana Prundean [France] ; Katia Youssov ; Sandrine Humbert ; Dominique Bonneau ; Christophe Verny | A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease. |
| 001937 (2010) |
Stephen Gancher [États-Unis] ; John Nutt [États-Unis] | Tolerance to apomorphine develops and reverses rapidly |
| 002B91 (2007) |
Björn Holmberg [Suède] ; Jan-Ove Johansson [Suède] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Nil Dizdar [Suède] ; Olivier Rascol [France] ; Tarik Slaoui [France] | Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study |
| 002D66 (2007) |
Christopher Kenney [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis] | Long‐term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders |
| 002E59 (2007) |
| Entacapone to tolcapone switch: Multicenter double‐blind, randomized, active‐controlled trial in advanced Parkinson's disease |
| 002E65 (2007) |
Günther Deuschl [Allemagne] ; Antanas Vaitkus [Lituanie] ; Gabriele-Cornelia Fox ; Torsten Roscher ; Dieter Schremmer [Allemagne] ; Ariel Gordin | Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing‐off |
| 002E70 (2007) |
Mayumi Kitagawa [Japon] ; Hideki Houzen [Japon] ; Kunio Tashiro [Japon] | Effects of caffeine on the freezing of gait in Parkinson's disease |
| 003062 (2007) |
Carlos Singer [États-Unis] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Gary Layton [Royaume-Uni] | A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease |
| 003152 (2006) |
Samay Jain [États-Unis] ; Paul E. Greene [États-Unis] ; Steven J. Frucht [États-Unis] | Tetrabenazine therapy of pediatric hyperkinetic movement disorders |
| 003302 (2006) |
Joseph H. Friedman [États-Unis] ; Robert M. Berman [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stewart A. Factor [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; William H. Carson [États-Unis] ; Ronald N. Marcus [États-Unis] | Open‐label flexible‐dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease |
| 003551 (2006) |
Richard Dubinsky [États-Unis] ; Carolyn Gray [États-Unis] | CYTE‐I‐HD: Phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease |
| 003766 (2005) |
Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Michael S. Okun [États-Unis] | Rebound psychosis: Effect of discontinuation of antipsychotics in Parkinson's disease |
| 003C17 (2004) |
Kai Wohlfarth [Allemagne] ; Knut Kampe [Royaume-Uni] ; Hans Bigalke [Allemagne] | Pharmacokinetic properties of different formulations of botulinum neurotoxin type A |
| 003F71 (2003) |
Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon] ; Kazuko Hasegawa [Japon] ; Hideki Origasa [Japon] ; Hisayuki Kowa [Japon] | Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease |
| 004048 (2003) |
Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Monica A. Burke [États-Unis] ; Carol Jacques [États-Unis] ; Joseph H. Friedman [États-Unis] | Long‐term outcome of quetiapine use for psychosis among parkinsonian patients |
| 004798 (2001) |
J. Eric Ahlskog [États-Unis] ; Manfred D. Muenter [États-Unis] | Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature |
| 004B05 (2000) |
Jan P. Larsen [Norvège] ; Karen Karlsen [Norvège] ; Elise Tandberg [Norvège] | Clinical problems in non‐fluctuating patients with Parkinson's disease: A community‐based study |
| 004B14 (2000) |
Dirk Dressler [Allemagne] ; Uwe Zettl [Allemagne] ; Reiner Benecke [Allemagne] ; Hans Bigalke [Allemagne] | Can intravenous immunoglobulin improve antibody‐mediated botulinum toxin therapy failure? |
| 004B88 (2000) |
Néstor Galvez-Jimenez [États-Unis] ; Maurice R. Hanson [États-Unis] ; Josh Cabral [États-Unis] | Dopa-resistant parkinsonism, oculomotor disturbances, chorea, mirror movements, dyspraxia, and dementia : The expanding clinical spectrum of hypoparathyroidism. A case report |
| 004B98 (1999) |
| Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients. Tolcapone Study Group. |
| 005370 (1997) |
Sampaio ; Joaquim J. Ferreira ; Fernanda Sim Es [Portugal] ; Maria J. Rosas [Portugal] ; Marina Magalhães [Portugal] ; Ana P. Correia [Portugal] ; Ant Nio Bastos-Lima [Portugal] ; Rairnundo Martins [Portugal] ; Alexandre Castro-Caldas | DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1 |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Drug Tolerance"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i \
-Sk "Drug Tolerance" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= indexItem
|index= Mesh.i
|clé= Drug Tolerance
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
